Back to News
Market Impact: 0.1
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Cellectis S.A. – CLLS
Source: globenewswire.com
Legal & LitigationHealthcare & Biotech
Pomerantz LLP said it is investigating claims on behalf of investors in Cellectis S.A. (NASDAQ: CLLS). The notice provided contact information for investors but no allegations, findings, or financial details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
neutral
Sentiment Score
-0.10
Ticker Sentiment
CLLS-0.50
More News
- Before Tera’s 95% Crash, Punches Were Thrown and Warnings Missed
- A top medical technology stock is trading at a big discount. Here's why I'm buying
- Obsessed with CoreWeave and the AI trade? You're missing out on some great stocks
- UnitedHealthcare and Humana are ending Medicare Advantage plans for nearly 1 million people
- Why is Intuitive Surgical stock sliding today?
- Disc Medicine prices $450 million stock offering at $75/share